Jane Street’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-10,600
Closed -$206K – 10429
2021
Q3
$206K Buy
+10,600
New +$205K ﹤0.01% 8794

Other funds holding INMB

Jane Street's INMB Position: Q3 2026 in Review

Jane Street increased its INmune Bio (INMB) stake by 22% in Q3 2026, buying an estimated $60.9K and bringing the position to 163,858 shares worth $320K. The position accounts for ﹤0.01% of the portfolio, ranked #9032.

Jane Street first reported a position in INMB in Q1 2021 and has held it in 11 quarters since. The position peaked at $869K in Q1 2024. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Jane Street held 163,858 shares of INmune Bio worth $320K as of Q3 2026.
  • Jane Street bought 29,626 INmune Bio shares in Q3 2026, an estimated $60.9K.
  • INmune Bio made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #9032 holding.
  • Jane Street first reported a position in INmune Bio in Q1 2021 and has held it in 11 quarters since.
  • Jane Street's INmune Bio position peaked at $869K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.